These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17199026)

  • 1. Stiripentol.
    Chiron C
    Neurotherapeutics; 2007 Jan; 4(1):123-5. PubMed ID: 17199026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stiripentol.
    Chiron C
    Expert Opin Investig Drugs; 2005 Jul; 14(7):905-11. PubMed ID: 16022579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stiripentol: an example of antiepileptic drug development in childhood epilepsies.
    Nabbout R; Chiron C
    Eur J Paediatr Neurol; 2012 Sep; 16 Suppl 1():S13-7. PubMed ID: 22695038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Starting stiripentol in adults with Dravet syndrome? Watch for ammonia and carnitine.
    Zulfiqar Ali Q; Marques P; Selvarajah A; Tabarestani S; Sadoway T; Andrade DM
    Epilepsia; 2020 Nov; 61(11):2435-2441. PubMed ID: 33084037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stiripentol: efficacy and tolerability in children with epilepsy.
    Perez J; Chiron C; Musial C; Rey E; Blehaut H; d'Athis P; Vincent J; Dulac O
    Epilepsia; 1999 Nov; 40(11):1618-26. PubMed ID: 10565591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological considerations in the use of stiripentol for the treatment of epilepsy.
    Verrotti A; Prezioso G; Stagi S; Paolino MC; Parisi P
    Expert Opin Drug Metab Toxicol; 2016; 12(3):345-52. PubMed ID: 26890312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of stiripentol in children and adults with epilepsy: the influence of dose, age, and comedication.
    May TW; Boor R; Mayer T; Jürgens U; Rambeck B; Holert N; Korn-Merker E; Brandt C
    Ther Drug Monit; 2012 Aug; 34(4):390-7. PubMed ID: 22743350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism.
    Giraud C; Treluyer JM; Rey E; Chiron C; Vincent J; Pons G; Tran A
    Drug Metab Dispos; 2006 Apr; 34(4):608-11. PubMed ID: 16415114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic drugs for the treatment of severe myoclonic epilepsy in infancy.
    Brigo F; Storti M
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010483. PubMed ID: 24254932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
    Morimoto M; Shimakawa S; Hashimoto T; Kitaoka T; Kyotani S
    J Clin Pharm Ther; 2018 Aug; 43(4):571-573. PubMed ID: 29265387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapeutic procedures in Dravet syndrome.
    Chiron C
    Dev Med Child Neurol; 2011 Apr; 53 Suppl 2():16-8. PubMed ID: 21504427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy.
    Jogamoto T; Yamamoto Y; Fukuda M; Suzuki Y; Imai K; Takahashi Y; Inoue Y; Ohtsuka Y
    Epilepsy Res; 2017 Feb; 130():7-12. PubMed ID: 28081475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of CYP2C19 polymorphisms on stiripentol administration in Japanese cases of Dravet syndrome.
    Kouga T; Shimbo H; Iai M; Yamashita S; Ishii A; Ihara Y; Hirose S; Yamakawa K; Osaka H
    Brain Dev; 2015 Feb; 37(2):243-9. PubMed ID: 24819914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy.
    Brigo F; Igwe SC; Bragazzi NL
    Cochrane Database Syst Rev; 2017 May; 5(5):CD010483. PubMed ID: 28521067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2015 Oct; (10):CD010483. PubMed ID: 26482210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?
    Chiron C; Helias M; Kaminska A; Laroche C; de Toffol B; Dulac O; Nabbout R; An I
    Epilepsia; 2018 Sep; 59(9):1705-1717. PubMed ID: 30132836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
    Patsalos PN; Szaflarski JP; Gidal B; VanLandingham K; Critchley D; Morrison G
    Epilepsia; 2020 Sep; 61(9):1854-1868. PubMed ID: 32918835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2015 Jul; 113():90-7. PubMed ID: 25986195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy.
    Trivisano M; Specchio N; Vigevano F
    Eur J Paediatr Neurol; 2015 Mar; 19(2):248-50. PubMed ID: 25510386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stiripentol for the treatment of seizures associated with Dravet syndrome.
    Chiron C
    Expert Rev Neurother; 2019 Apr; 19(4):301-310. PubMed ID: 30900478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.